Ultrathin water layers on mannosylated gold nanoparticles

• Maiara A. Iriarte Alonso,
• Jorge H. Melillo,
• Silvina Cerveny,
• Yujin Tong and
• Alexander M. Bittner

Beilstein J. Nanotechnol. 2025, 16, 2183–2198, doi:10.3762/bjnano.16.151

• sensing, imaging, or drug delivery systems. The success of these platforms stems from their dispersion in water, stability, and biocompatibility in fully hydrated states, as well as in biological fluids. Our investigation shows a novel approach to these particles by testing the hydration properties under

Toward clinical translation of carbon nanomaterials in anticancer drug delivery: the need for standardisation

• Michał Bartkowski,
• Francesco Calzaferri and
• Silvia Giordani

Beilstein J. Nanotechnol. 2025, 16, 2092–2104, doi:10.3762/bjnano.16.144

• translational hurdles, extend broadly across therapeutic contexts. Regardless of indication, many of the key challenges in standardising CNM-based drug delivery systems remain largely the same. Using carbon nanocarrier to address the global burden of cancer Cancer, a group of diseases characterised by

• a lack of standardised methods for measuring these properties, which can make it difficult to compare results across studies and to ensure the safety and efficacy of CNM-based drug delivery systems. Efforts are underway to address these issues and to establish standardised methods for the synthesis

• improve the reproducibility and comparability of results across studies and to facilitate the regulatory approval of carbon nanomaterial-based drug delivery systems. Model therapeutics in nanocarrier development Chemotherapy drugs are designed to kill rapidly dividing cancer cells by disrupting their cell

Beyond the shell: exploring polymer–lipid interfaces in core–shell nanofibers to carry hyaluronic acid and β-caryophyllene

• Aline Tavares da Silva Barreto,
• Francisco Alexandrino-Júnior,
• Bráulio Soares Arcanjo,
• Paulo Henrique de Souza Picciani and
• Kattya Gyselle de Holanda e Silva

Beilstein J. Nanotechnol. 2025, 16, 2015–2033, doi:10.3762/bjnano.16.139

• thermoplastic known for its biodegradability, biocompatibility, and bioabsorbability [20][21]. Highly attractive due to its versatile physical, chemical, and biological properties, PLA is a suitable option for manufacturing tissue engineering scaffolds, implantable devices, and drug delivery systems, holding

PEGylated lipids in lipid nanoparticle delivery dynamics and therapeutic innovation

• Peiyang Gao

Beilstein J. Nanotechnol. 2025, 16, 1914–1930, doi:10.3762/bjnano.16.133

• strategies in LNP-based drug delivery systems, approaches are being explored. These include integrating functional groups into PEG lipids for ligand conjugation and improved cell-specific targeting, as well as developing PEG alternatives to mitigate anti-PEG antibody associated immunogenicity [7][8]. This

Phytol-loaded soybean oil nanoemulsion as a promising alternative against Leishmania amazonensis

• Victória Louise Pinto Freire,
• Mariana Farias Alves-Silva,
• Johny W. de Freitas Oliveira,
• Matheus de Freitas Fernandes-Pedrosa,
• Alianda Maira Cornélio,
• Marcelo de Souza-Silva,
• Thayse Silva Medeiros and
• Arnóbio Antônio da Silva Junior

Beilstein J. Nanotechnol. 2025, 16, 1826–1836, doi:10.3762/bjnano.16.126

• pharmaceutical application by reducing bioavailability [18]. To overcome these limitations, the incorporation of phytol into nanostructured delivery systems, has been proposed to improve its solubility, stability, and intracellular delivery efficiency [19]. Nanotechnology-based drug delivery systems that

Exploring the potential of polymers: advancements in oral nanocarrier technology

• Rousilândia de Araujo Silva,
• Igor Eduardo Silva Arruda,
• Luise Lopes Chaves,
• Mônica Felts de La Roca Soares and
• Jose Lamartine Soares Sobrinho

Beilstein J. Nanotechnol. 2025, 16, 1751–1793, doi:10.3762/bjnano.16.122

• , Brazil 10.3762/bjnano.16.122 Abstract Polymers play a pivotal role in various drug delivery systems due to their versatility, with polymeric nanoparticles showing significant potential to overcome physiological barriers associated with oral administration. This review examines the current advancements

• used polymers. Although polymerization-based techniques allow for precise tailoring of nanoparticle architecture, they present significant limitations that restrict their broader application, particularly in oral drug delivery systems, where biocompatibility and safety are critical. These methods

• macromolecules composed of repeating monomers linked by covalent bonds [90]. These materials are highly attractive as vehicles for oral drug delivery systems due to their strong mucosal adhesion properties and their ability to enhance paracellular transport of drug molecules. Additionally, they are easy to

Advances of aptamers in esophageal cancer diagnosis, treatment and drug delivery

• Yang Fei,
• Hui Xu,
• Chunwei Zhang,
• Jingjing Wang and
• Yong Jin

Beilstein J. Nanotechnol. 2025, 16, 1734–1750, doi:10.3762/bjnano.16.121

• , coupling drugs, covalent binding with siRNA, and chemical modification [34][35] to promote their role in cancer drug delivery. Conventional drug delivery systems, including metal nanoparticles, nanohydrogels, liposomes, and polymeric micelles [36][37][38], have gained widespread adoption due to their

• of therapeutic efficacy. Recent breakthroughs in aptamer-based targeted therapeutics have marked significant advancements, revitalizing prospects for novel therapeutic aptamer developments. In addition, aptamer-based drug delivery systems can not only accurately identify lesions, but also improve

• [106] and stimuli-responsive drug delivery systems [107], represent significant advances toward enhanced therapeutic efficacy and precision medicine. However, most nanomedicines still require intravenous injection [108], and there is no precedent for AFDNs in EC clinical trials; however, this advanced

Multifunctional anionic nanoemulsion with linseed oil and lecithin: a preliminary approach for dry eye disease

• Niédja Fittipaldi Vasconcelos,
• Almerinda Agrelli,
• Rayane Cristine Santos da Silva,
• Carina Lucena Mendes-Marques,
• Isabel Renata de Souza Arruda,
• Priscilla Stela Santana de Oliveira,
• Mércia Liane de Oliveira and
• Giovanna Machado

Beilstein J. Nanotechnol. 2025, 16, 1711–1733, doi:10.3762/bjnano.16.120

• for therapeutic effectiveness. In contrast to traditional drug delivery systems (DDS), a functional ophthalmic nanoemulsion was specifically designed to alleviate symptoms of DED by leveraging its antioxidant and osmoprotective properties. The study evaluated the optimal concentration of lecithin

• begins to form on the droplet interface. While cationic and anionic nanoemulsions are commonly explored in drug delivery systems due to their distinct electrostatic properties, the present formulation was not designed as a drug delivery vehicle. Instead, it functions as a bioactive nanoemulsion intended

Prospects of nanotechnology and natural products for cancer and immunotherapy

• Jan Filipe Andrade Santos,
• Marcela Bernardes Brasileiro,
• Pamela Danielle Cavalcante Barreto,
• Ligiane Aranha Rocha and
• José Adão Carvalho Nascimento Júnior

Beilstein J. Nanotechnol. 2025, 16, 1644–1667, doi:10.3762/bjnano.16.116

• hydrophilic or lipophilic pharmaceutical drugs, as well as surface modification, making PNCs advantageous for controlled drug delivery systems [132]. PNCs hold potential applications for cancer treatment and immunotherapy. They can provide sustained drug release while decreasing cytotoxicity and modifying

Venom-loaded cationic-functionalized poly(lactic acid) nanoparticles for serum production against Tityus serrulatus scorpion

• Philippe de Castro Mesquita,
• Karla Samara Rocha Soares,
• Manoela Torres-Rêgo,
• Emanuell dos Santos-Silva,
• Mariana Farias Alves-Silva,
• Alianda Maira Cornélio,
• Matheus de Freitas Fernandes-Pedrosa and
• Arnóbio Antônio da Silva-Júnior

Beilstein J. Nanotechnol. 2025, 16, 1633–1643, doi:10.3762/bjnano.16.115

• vitro, creates a challenge for drug delivery systems aiming to effectively target affected tissues or cells [14][15]. Nanocarriers have been widely studied for enabling prolonged circulation and sustained drug release over time, depending on their structural properties [16][17]. Therefore, protein

Nanomaterials for biomedical applications

• Iqra Zainab,
• Zohra Naseem,
• Syeda Rubab Batool,
• Filippo Pierini,
• Seda Kizilel and
• Muhammad Anwaar Nazeer

Beilstein J. Nanotechnol. 2025, 16, 1499–1503, doi:10.3762/bjnano.16.105

• and biocompatibility [14]. In general, smart drug delivery systems developed from nanomaterials are changing the concept of delivering therapies. With lower drug dosing, it helps patients quickly recover with fewer side effects, which is necessary for chronic or life-threatening diseases. Due to all

Enhancing the therapeutical potential of metalloantibiotics using nano-based delivery systems

• Alejandro Llamedo,
• Marina Cano,
• Raquel G. Soengas and
• Francisco J. García-Alonso

Beilstein J. Nanotechnol. 2025, 16, 1350–1366, doi:10.3762/bjnano.16.98

• application of metalloantibiotics is limited by their potential toxicity, instability, and lack of target specificity. Encapsulating metalloantibiotics in drug delivery systems, such as liposomes, nanoparticles, and polymeric carriers, could mitigate these challenges, enhancing their therapeutic index and

• .; Liu, G. Nanoscale 2025, 17, 5605–5628. doi:10.1039/D4NR04774E ]. This review explores the potential of encapsulated metalloantibiotics as a new frontier in antimicrobial therapy. We address the mechanisms by which drug delivery systems can stabilize and direct metalloantibiotics to their biological

• mechanisms of nanotechnology-based drug delivery systems, followed by their integration with metal-based complexes. Finally, it discusses the challenges and future perspectives of this emerging field, emphasizing its potential to revolutionize the fight against bacterial infections and antimicrobial

Ferroptosis induction by engineered liposomes for enhanced tumor therapy

• Alireza Ghasempour,
• Mohammad Amin Tokallou,
• Mohammad Reza Naderi Allaf,
• Mohsen Moradi,
• Hamideh Dehghan,
• Mahsa Sedighi,
• Mohammad-Ali Shahbazi and
• Fahimeh Lavi Arab

Beilstein J. Nanotechnol. 2025, 16, 1325–1349, doi:10.3762/bjnano.16.97

• [109]. The synthesis and characterization of liposomes are crucial steps to ensure their efficacy and safety as drug delivery systems [110]. 3.1 Design and engineering of liposomes Numerous liposome preparation methods affect their properties, including size, layer structure, and encapsulation

• high EE and stability [117]. These new technologies in liposome synthesis offer improved methods for producing liposomes with customized properties, which increased their potential as drug delivery systems for various therapeutic applications [114][117][118][119]. The optimal method of liposome

• ][120]. 3.2 Characterization of liposomes Characterization of liposomes is important to ensure their quality and performance as drug delivery systems. Several techniques are commonly used to analyze the properties of liposomes, including size, lamellarity, surface charge, and EE [110][121]. Dynamic

Better together: biomimetic nanomedicines for high performance tumor therapy

• Imran Shair Mohammad,
• Gizem Kursunluoglu,
• Anup Kumar Patel,
• Hafiz Muhammad Ishaq,
• Cansu Umran Tunc,
• Dilek Kanarya,
• Mubashar Rehman,
• Omer Aydin and
• Yin Lifang

Beilstein J. Nanotechnol. 2025, 16, 1246–1276, doi:10.3762/bjnano.16.92

• feasible biomimetic nanoplatforms, other cell membrane-coated drug delivery systems also provide promising therapeutic strategies [130][131][132]. Nanomaterials camouflaged with cancer cell membrane (CCM) have been used for a number of theranostic applications [133][134]. Rao et al. showed that CCM-coated

• surrounding environment, including immunosuppression in T cells via PD-1/PD-L1 axis, recruitment of stem cells via CXCR4/CXCL2 chemokine axis, maturation of immune cells via membrane interactions, and various other physical/chemical interactions, uncover the emergence of cell membrane-based drug delivery

• delivery systems interact with different body structures as well as physiologic environments. Thus, the structures of drug carriers must be constructed in a way that allows them to elude immune recognition and overcome barriers via effective bio-interfacing. Within the scope of biomimetic nanomedicine for

Hydrogels and nanogels: effectiveness in dermal applications

• Jéssica da Cruz Ludwig,
• Diana Fortkamp Grigoletto,
• Daniele Fernanda Renzi,
• Wolf-Rainer Abraham,
• Daniel de Paula and
• Najeh Maissar Khalil

Beilstein J. Nanotechnol. 2025, 16, 1216–1233, doi:10.3762/bjnano.16.90

• - Vila Carli, Guarapuava – PR, Brazil Helmholtz-Zentrum für Infektionsforschung, Inhoffenstrasse 7, 38124 Braunschweig, Germany 10.3762/bjnano.16.90 Abstract Drug delivery systems (DDSs) are an important tool for obtaining medicines with improved physicochemical properties, especially for drugs with

• -1950s and 1960s [1][2][3][4]. From the beginning, hydrogels composed of cross-linked acrylic acid were designed to release drugs into the body [5]. 2-Hydroxyethyl methacrylate was one of the first compounds used to build hydrogels as drug delivery systems (DDSs) [6]. Over the past century, hydrogels

• the extracellular matrix make them attractive drug delivery systems. Dermal applications include psoriasis treatment, antimicrobial activity, wound healing, and skin tumor remission. Understanding topical and transdermal drug delivery mechanisms is crucial. Hydrogels and nanogels, proven strategies to

Investigation of the solubility of protoporphyrin IX in aqueous and hydroalcoholic solvent systems

• Michelly de Sá Matsuoka,
• Giovanna Carla Cadini Ruiz,
• Marcos Luciano Bruschi and
• Jéssica Bassi da Silva

Beilstein J. Nanotechnol. 2025, 16, 1209–1215, doi:10.3762/bjnano.16.89

• its bioavailability and light absorption capacity will be increased [5]. To overcome this problem, the development of drug delivery systems, such as poloxamer-based ones, has played an important role on the delivery of dyes for PDT [8][9][10]. Poloxamers are triblock copolymers with thermosensitive

• optimize the development of new drug delivery systems for PDT applications. Moreover, the potential of P407 as a feasible system for PpIX delivery was also evaluated in different media. Experimental Preparation of the systems The systems were prepared at least 24 h before the test and used for up to seven

Soft materials nanoarchitectonics: liquid crystals, polymers, gels, biomaterials, and others

• Katsuhiko Ariga

Beilstein J. Nanotechnol. 2025, 16, 1025–1067, doi:10.3762/bjnano.16.77

A formulation containing Cymbopogon flexuosus essential oil: improvement of biochemical parameters and oxidative stress in diabetic rats

• Ailton Santos Sena-Júnior,
• Cleverton Nascimento Santana Andrade,
• Pedro Henrique Macedo Moura,
• Jocsã Hémany Cândido dos Santos,
• Cauãn Torres Trancoso,
• Eloia Emanuelly Dias Silva,
• Deise Maria Rego Rodrigues Silva,
• Ênio Pereira Telles,
• Luiz André Santos Silva,
• Isabella Lima Dantas Teles,
• Sara Fernanda Mota de Almeida,
• Daniel Alves de Souza,
• Jileno Ferreira Santos,
• Felipe José Aidar Martins,
• Ana Mara de Oliveira e Silva,
• Sandra Lauton-Santos,
• Guilherme Rodolfo Souza de Araujo,
• Cristiane Bani Correa,
• Rogéria De Souza Nunes,
• Lysandro Pinto Borges and
• Ana Amélia Moreira Lira

Beilstein J. Nanotechnol. 2025, 16, 617–636, doi:10.3762/bjnano.16.48

• antidyslipidemic properties in vivo [4][5][6]. EOs are volatile components that are sensitive to temperature, light, oxygen, and humidity [7]. Therefore, it is recommended to use them in drug delivery systems, such as nanostructured systems, which are able to guarantee stability and a better therapeutic effect

• of MEs is advantageous when taken orally as it facilitates oral application and dose adjustment; it also improves absorption and bioavailability. Additionally, MEs can be administered to humans as self-microemulsifying drug delivery systems (SMEDDSs) delivered in soft gelatin capsules as they are low

Polyurethane/silk fibroin-based electrospun membranes for wound healing and skin substitute applications

• Iqra Zainab,
• Zohra Naseem,
• Syeda Rubab Batool,
• Muhammad Waqas,
• Ahsan Nazir and
• Muhammad Anwaar Nazeer

Beilstein J. Nanotechnol. 2025, 16, 591–612, doi:10.3762/bjnano.16.46

• the development of implants, medical devices, and drug delivery systems that solve challenging issues from health to medicine [5]. Because of innovations in tissue engineering, genetic engineering, and nanotechnology, scientists can now see into the innermost functions of living organisms with a level

• surrounding tissues [172]. In addition, they are also vital in advanced drug delivery systems where highly specific and localized release of drugs can be achieved through light, thus increasing the efficiency of various therapies [173]. Rybak et al. formulated a new 3D-printed hydrogel wound dressing for

• , scaffolds for tissue engineering, and drug delivery systems possible. These developments are essential for adjusting the composites’ biological and physical characteristics, which will enhance patient outcomes [178]. Researchers have thoroughly investigated the potential of electrospun composites based on

Nanomaterials in targeting amyloid-β oligomers: current advances and future directions for Alzheimer's disease diagnosis and therapy

• Shiwani Randhawa,
• Trilok Chand Saini,
• Manik Bathla,
• Rahul Bhardwaj,
• Rubina Dhiman and
• Amitabha Acharya

Beilstein J. Nanotechnol. 2025, 16, 561–580, doi:10.3762/bjnano.16.44

Effect of additives on the synthesis efficiency of nanoparticles by laser-induced reduction

• Rikuto Kuroda,
• Takahiro Nakamura,
• Hideki Ina and
• Shuhei Shibata

Beilstein J. Nanotechnol. 2025, 16, 464–472, doi:10.3762/bjnano.16.35

• including electrode materials [1], conductive pastes [2][3], catalysts [4][5], sensors [6][7][8], and drug delivery systems [9]. The chemical reduction [10] and the solvothermal methods [11][12] are well known for synthesizing nanoparticles in large quantities at low cost, but these methods require the use

Synthetic-polymer-assisted antisense oligonucleotide delivery: targeted approaches for precision disease treatment

• Ana Cubillo Alvarez,
• Dylan Maguire and
• Ruairí P. Brannigan

Beilstein J. Nanotechnol. 2025, 16, 435–463, doi:10.3762/bjnano.16.34

• in ASO-based therapies. Some promising strategies to overcome these limitations involve the conjugation of ASOs with peptides [53], polymers [54], aptamers [55], and antibodies [56], as well as the development of novel drug delivery systems [57][58]. This review discusses the challenges associated

• internalisation mechanism for PLL-conjugated ASOs [67]. Specific molecular structures, however, can be utilised to facilitate the targeted uptake of drug delivery systems. Ligand–PLL–ASO conjugates, for instance, can enter target cells via receptor-mediated endocytosis [68]. This approach holds promise for

• conjugated drugs or drug delivery systems. For example, early studies by Zheng et al. demonstrated a strategic use of PLL conjugated to galactose (Gal–PLL, Gal/PLL = 10:1) as a carrier for a 16-mer phosphorothioate analogue of the antisense oligodeoxynucleotide 5′-CATGCCCCAAAGCCAC-3′, targeting the hepatitis

Development of a mucoadhesive drug delivery system and its interaction with gastric cells

• Ahmet Baki Sahin,
• Serdar Karakurt and
• Deniz Sezlev Bilecen

Beilstein J. Nanotechnol. 2025, 16, 371–384, doi:10.3762/bjnano.16.28

• both situations, the effectiveness of the drug formulation depends on several factors such as gastric residence time, gastric emptying, release rate of the drug from the dosage form, and the therapeutic agent reaching the site of action or absorption. Conventional drug delivery systems may not be

• effective in overcoming these obstacles, particularly regarding drugs that are designed for the treatment of local gastric diseases [3]. The solution to this is the development of gastroretentive drug delivery systems. These are designed to increase the drug residence time in the upper part of the

• gastrointestinal system, which leads to higher effectiveness [4][5]. Over the years, different types of gastroretentive drug delivery systems have been developed, including floating, expandable, high-density, or mucoadhesive systems [6]. Among these, mucoadhesive systems are quite effective in localizing the drugs

Enhancing mechanical properties of chitosan/PVA electrospun nanofibers: a comprehensive review

• Nur Areisman Mohd Salleh,
• Amalina Muhammad Afifi,
• Fathiah Mohamed Zuki and
• Hanna Sofia SalehHudin

Beilstein J. Nanotechnol. 2025, 16, 286–307, doi:10.3762/bjnano.16.22

• efficient sustained release. These nanofibers also exhibit better stability, which are vital properties in drug delivery systems [183][184]. These superior properties have gained recent attention for enhancing the functional performance of chitosan-based nanofibers. Core–shell chitosan nanofibers have been

Recent advances in photothermal nanomaterials for ophthalmic applications

• Jiayuan Zhuang,
• Linhui Jia,
• Chenghao Li,
• Rui Yang,
• Jiapeng Wang,
• Wen-an Wang,
• Heng Zhou and
• Xiangxia Luo

Beilstein J. Nanotechnol. 2025, 16, 195–215, doi:10.3762/bjnano.16.16

• neuropathy [125][126]. Currently, ocular drug delivery is the prevalent treatment approach; however, it faces challenges due to drug degradation and obstacles in drug diffusion, rendering the therapy less effective [127][128]. Therefore, ocular drug delivery systems capable of controlled and sustained drug

• energy into heat, which then triggers the release of the cargo from a heat-sensitive carrier [165]. Photothermal drug delivery systems allow for precise spatial and temporal control of drug release based on stimulus intensity and duration, thereby reducing the need for invasive ocular injections for the

• treatment of chronic ocular diseases, as well as the “explosive release” of passive drug delivery systems [116]. Furthermore, photothermal drug delivery systems can be surface-modified to prolong drug residence time, improve mobility, avoid trapping, and provide targeting capabilities, which helps to